Investing

Red-Hot Biotech Highlights Stocks to Buy Under $10 With Huge Upside

Bioscrip

This company has a growing market share and could be a takeover candidate. BioScrip Inc. (NASDAQ: BIOS) is engaged in providing infusion solutions. It partners with physicians, hospital systems, skilled nursing facilities, health care payers and pharmaceutical manufacturers to provide patients access to post-acute care services.

The company offers home infusion services to provide clinical management services and the delivery of prescription medications. BioScrip provides services in coordination with, and under the direction of, the patient’s physician.

The $5 SunTrust target price compares with the $4.17 consensus price target. Shares were last seen trading at $3.88.

Evoqua Water Technologies

This stock has been crushed, but it remains in a sector that has monster upside. Evoqua Water Technologies Corp. (NASDAQ: AQUA) is focused on providing water treatment solutions. The company offers services, systems and technologies to support customers’ full water lifecycle needs.

Evoqua offers a comprehensive portfolio of differentiated, proprietary technology solutions, and the company operates through three segments. The Industrial segment provides application-specific solutions and full lifecycle services for critical water applications that selectively utilize its comprehensive portfolio of water treatment technologies to satisfy its customers’ unique water needs.

The Municipal segment provides engineered solutions and equipment for the treatment of wastewater, purification of drinking water and odor and corrosion control for municipalities.

Lastly, the Products segment sells differentiated technologies to a diverse set of water treatment system specifiers, integrators and end users globally.

RBC has a $13 price objective. The consensus target price is $12, and the shares closed Friday at $9.96 apiece.

Intec Pharma

This is a biotech play for aggressive accounts looking for big-time alpha potential. Intec Pharma Ltd. (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company’s Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

The company’s product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa is in late-stage Phase 3 development for the treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients. AP-cannabinoids, an Accordion Pill to deliver either or both of the primary cannabinoids contained in cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various pain indications.

The Oppenheimer price target on the shares is a massive $15. The consensus target is lower at $12.70, and the stock ended the week at $7.35 per share.

These five stocks trading under the $10 level have big upside to the analysts’ price targets. Again, while they are not suitable for conservative accounts, aggressive investors can get some solid share leverage buying 5000, 10,000 or more shares and can make money on a much smaller share price move. Plus they are all covered with Buy ratings at top firms across Wall Street.

And for a last consideration, the end of 2018 has been trading like many of the bear markets of the past. Analyst target prices seem to not matter on most days, and many stocks sell off for the same reasons over and over. Please read the 24/7 Wall St. piece about dire warnings surrounding analyst calls during bear markets to help avoid some serious pitfalls.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.